To gain more insight into the pathways by which FLCN suppresses renal tumorigenesis, we created FLCNPOS and FLCNNEG human renal tubular epithelial cell lines to model BHD syndrome in vitro. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.